arrow
S

Stéphane Pyronnet

Cancer Research Center of Toulouse
H指数:40
被引数:6,189

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Bimodal silencing of the acinar cell-specific mRNA translation repressor PAIP2B defines a poor prognostic subgroup within the classical pancreatic tumor type” [Cancer Lett. 632 (2025) 217971]

勘误:针对“经典型胰腺肿瘤类型中,腺泡细胞特异性mRNA翻译抑制因子PAIP2B的双模沉默定义了一个预后不良的亚群”[Cancer Lett. 632 (2025) 217971]

2025-12-040
OAAI
Mechanisms for stroma-induced secondary chemoresistance in pancreatic adenocarcinoma

基质诱导的胰腺腺癌继发性化疗抵抗的机制

2025-10-310
PRE
Unveiling FKBP7 as an early endoplasmic reticulum sentinel in pancreatic stellate cell activation, collagen remodeling and tumor progression

揭示FKBP7作为胰腺星状细胞活化、胶原重塑和肿瘤进展中早期内质网哨兵的作用

2025-04-011
OAAI
A strong internal promoter drives massive expression of YEATS-domain devoid MLLT3 transcripts in HSC and most lethal AML

强大的内部启动子驱动造血干细胞(HSC)和最致命的急性髓系白血病(AML)中缺乏YEATS结构域的MLLT3转录本的巨大表达。

2025-01-030
OAAI
A Switch of G Protein-Coupled Receptor Binding Preference from Phosphoinositide 3-Kinase (PI3K)-p85 to Filamin A Negatively Controls the PI3K Pathway

从磷酸肌醇3-激酶 (PI3K)-p85到细丝蛋白A的g蛋白偶联受体结合偏好的转换负控制PI3K途径

2023-03-2036
OAAI
Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages
2021-01-0123
OAAI
FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer

癌症相关成纤维细胞中的FAK活性是胰腺癌的预后标志物和可药的关键转移参与者

2020-10-0767
OAAI